pharma&
Elizabeth Persons is an experienced financial professional currently serving as the Cost Accounting Manager at pharma& since July 2023. Prior to this role, Elizabeth held similar positions at Clovis Oncology from July 2018 to June 2023, where responsibilities included inventory costing, manufacturing accruals, and reporting. Elizabeth also served as Accounting Manager at Versacart Systems, Inc., managing all accounting functions and streamlining month-end processes from November 2013 to July 2018. Previous positions include Assistant Controller at Advanced Forming Technology and Senior Accountant at Credit Union of Colorado, ensuring accurate financial reporting and compliance. Elizabeth began their career as an Accounting Manager at The SmartPill Corporation, developing financial processes for a startup, and also worked as an Operational Accountant at the Erie and Niagara Insurance Association. Elizabeth holds a Bachelor’s Degree in Accounting from the University at Buffalo.
This person is not in any offices
pharma&
1 followers
pharmaand GmbH (pharma&), a privately owned global company, aspires to breathe new life into proven medicines through our agile and fully integrated business model, guaranteeing the enduring availability, dependability, and quality of essential drugs worldwide that patients and healthcare providers rely on. Whether a former blockbuster or niche medicine, we acquire the worldwide rights to specialty treatments to secure long-term access to established and essential medicines across various specialized therapy areas, doing whatever it takes to maintain and develop the value of these medicines for all who depend on them. We’ve acquired and integrated 11 medicines over the past five years, expanding our portfolio across a wide range of therapy areas, with an increasing focus on hematology and oncology treatments. Our unique, fully integrated model across pharma&’s subsidiaries, joint ventures, and partners enables us to provide our portfolio of medicines to eligible healthcare providers and patients worldwide, spanning the continuum of manufacturing, distribution, administration/access, and patient support.